We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,574 results
  1. A Phase 2 Randomized Controlled Trial of Single-Agent Hydroxyurea Versus Thalidomide Among Adult Transfusion Dependent β Thalassemia Patients

    Hydroxyurea and low dose thalidomide are low-cost, easily accessible Hb F inducing agents that have been found to decrease transfusion dependency...

    Urmimala Bhattacharjee, Alka Khadwal, ... Pankaj Malhotra in Indian Journal of Hematology and Blood Transfusion
    Article 03 January 2023
  2. Selective Enhancement of Swine Myocardium with a Novel Ultrasound Enhancing Agent During Transthoracic Echocardiography

    Ultrasound enhancing agents are approved to delineate the endocardial border and opacify the left ventricle cavity (LVC). We present a nested phase...

    Michael Cimorelli, Michael A. Flynn, ... Steven Wrenn in Journal of Cardiovascular Translational Research
    Article 31 January 2022
  3. Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case–control study

    A lack of biomarkers that detect drug-induced liver injury (DILI) accurately continues to hinder early- and late-stage drug development and remains a...

    Jane I. Grove, Camilla Stephens, ... Guruprasad P. Aithal in Diagnostic and Prognostic Research
    Article Open access 12 September 2023
  4. Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials

    Introduction

    Risk factors for thromboembolic events in patients with dialysis-dependent chronic kidney disease (CKD) receiving roxadustat are unknown....

    Takayuki Hamano, Yusuke Yamaguchi, ... Jonathan Barratt in Advances in Therapy
    Article Open access 16 February 2024
  5. Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan

    Introduction

    Thromboembolic events have occurred in clinical trials of roxadustat. This post hoc analysis explored potential factors related to...

    Takayuki Hamano, Yusuke Yamaguchi, ... Tadao Akizawa in Advances in Therapy
    Article Open access 16 February 2024
  6. Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension

    Background

    Cognitive function can be affected in conditions with raised intracranial pressure (ICP) such as idiopathic intracranial hypertension...

    Olivia Grech, James L. Mitchell, ... Alexandra J. Sinclair in Eye
    Article Open access 11 January 2024
  7. Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia

    PLK1 is overexpressed in acute myeloid leukemia (AML). A phase 1b trial of the PLK1 inhibitor onvansertib (ONV) combined with decitabine (DAC)...

    Peter J P Croucher, Maya Ridinger, ... Amer M. Zeidan in Annals of Hematology
    Article Open access 13 September 2023
  8. Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models

    Objectives

    To investigate if nested multiparametric decision tree models based on tumor size and CT texture parameters from pre-therapeutic imaging...

    Jan Vosshenrich, Christoph J. Zech, ... Daniel T. Boll in European Radiology
    Article Open access 03 December 2020
  9. Computerized Relational Agent to Deliver Alcohol Brief Intervention and Referral to Treatment in Primary Care: a Randomized Clinical Trial

    Background

    Alcohol screening and brief intervention have demonstrated efficacy but limited effectiveness and implementation in real-world primary care...

    Amy Rubin, Nicholas A. Livingston, ... Steven Simon in Journal of General Internal Medicine
    Article 18 June 2021
  10. Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial

    Purpose

    Investigate safety and tolerability of adrecizumab, a humanized monoclonal adrenomedullin antibody, in septic shock patients with high...

    Pierre-François Laterre, Peter Pickkers, ... Tom Dormans in Intensive Care Medicine
    Article 04 October 2021
  11. A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects

    Background and Objective

    Trofinetide, a synthetic analog of tripeptide glycine-proline-glutamate, is an investigational agent for the treatment of...

    Mona Darwish, James M. Youakim, ... Serge Stankovic in Clinical Drug Investigation
    Article Open access 27 May 2022
  12. ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

    Background

    Dolutegravir (DTG)-based antiretroviral therapy (ART) is highly effective and well-tolerated in adults and is rapidly being adopted...

    Cecilia L. Moore, Anna Turkova, ... Anna Goodman in BMC Infectious Diseases
    Article Open access 04 January 2021
  13. A PK-PD model linking biomarker dynamics to progression-free survival in patients treated with everolimus and sorafenib combination therapy, EVESOR phase I trial

    Purpose

    The objective was to develop a pharmacokinetic-pharmacodynamic (PK-PD) model linking everolimus and sorafenib exposure with biomarker dynamics...

    Alicja Puszkiel, Benoit You, ... Michel Tod in Cancer Chemotherapy and Pharmacology
    Article 03 April 2023
  14. Molecular-based study of scrub typhus in Kerala, South India from 2014 to 2021: a laboratory-based study

    Scrub typhus (ST) is a neglected acute, febrile, infectious disease caused by the intracellular parasite Orientia tsutsugamushi , a gram-negative...

    Dayakar Seetha, Sai Ravi Chandra Nori, Radhakrishnan R. Nair in Comparative Clinical Pathology
    Article 01 February 2023
  15. Eight characteristics of rigorous multilevel implementation research: a step-by-step guide

    Background

    Although healthcare is delivered in inherently multilevel contexts, implementation science has no widely endorsed methodological standards...

    Rebecca Lengnick-Hall, Nathaniel J. Williams, ... Gregory A. Aarons in Implementation Science
    Article Open access 23 October 2023
  16. Teriparatide and pelvic fracture healing: a phase 2 randomized controlled trial

    Summary

    Pelvic fracture patients were randomized to blinded daily subcutaneous teriparatide (TPTD) or placebo to assess healing and functional...

    J.W. Nieves, F. Cosman, ... J. Lane in Osteoporosis International
    Article 12 August 2021
  17. Stress response during early sedation with dexmedetomidine compared with usual-care in ventilated critically ill patients

    Background

    Sedative agents may variably impact the stress response. Dexmedetomidine is a sympatholytic alpha 2 -adrenergic agonist mainly used as a...

    John P. R. Moore, Yahya Shehabi, ... Mervyn Singer in Critical Care
    Article Open access 22 November 2022
  18. Performance of cardiac PET/CT with and without phase analysis for detection of scar in cardiac sarcoidosis: Comparison to cardiac magnetic resonance imaging

    Background

    The presence of myocardial scar in CS patients results in poor prognosis and worse outcomes. 18 F-fluorodeoxyglucose ( 18 F-FDG) PET/CT...

    Mohamed Y. Elwazir, Jared G. Bird, ... John P. Bois in Journal of Nuclear Cardiology
    Article 20 January 2021
  19. Translational PK-PD/TD modeling of antitumor effects and peripheral neuropathy in gemcitabine and nab-paclitaxel chemotherapy from xenograft mice to patients for optimal dose and schedule

    Purpose

    Gemcitabine and nab-paclitaxel (GnP) treatment, the standard first-line chemotherapy for unresectable pancreatic cancer, often causes...

    Shinji Kobuchi, Atsuko Morita, ... Yukako Ito in Cancer Chemotherapy and Pharmacology
    Article 20 December 2023
  20. Management of pulmonary aspergillosis in children: a systematic review

    Invasive pulmonary aspergillosis (IPA) is a severe condition in immunocompromised children, but the optimal management is still under debate. In...

    Vito Terlizzi, Marco Antonio Motisi, ... Elena Chiappini in Italian Journal of Pediatrics
    Article Open access 28 March 2023
Did you find what you were looking for? Share feedback.